Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAFROOM: Caffeine in Delivery Room for Preterm Infants
NCT04044976Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Aug 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of caffeine in respiratory distress syndrome (RDS) and apnea of prematurity (AOP) (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoint: Success rate of intravenous or enteral administration of caffeine in the delivery room. Started Aug 2019; status: completed.
02
Drugs
caffeine
03
Conditions
respiratory distress syndrome (RDS)apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT04044976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04044976.